Clinical trials: sponsored by University of Minnesota
Breast Augmentation, Breast Reconstruction
A Pilot Study to Evaluate the BodyLogic TM System (Mentor) in Augmentation Mammaplasty
At a national level of 15%, the reoperation rate following augmentation mammaplasty is too high. We are conducting a survey to examine the pre-operative methods by which plastic surgeons determine implant volume, size, shape and…
- Trial name
- NCT00684749
- Where
- United States
- Volunteers
- 142 people
- Sponsor
- University of Minnesota
Cardiovascular Disease
Purple Grape Juice in Improving Vascular Health in Childhood Cancer Survivors
Rationale: Survivors of childhood cancer are at an increased risk of developing cardiovascular risk factors as well as early cardiovascular disease, likely due to the intensive therapeutic regimen used to treat their cancer.
- Trial name
- JAVA (NCT01043939)
- Testing
- Purple Grape Juice, Apple Juice
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- University of Minnesota
Food Selection
Pilot Study Using a Wireless Motility Capsule
Research suggests dietary fiber may decrease transit time through the gastrointestinal tract. Research studies traditionally use radio-opaque markers to determine gastric emptying, colonic transit, and whole gut transit time.
- Trial name
- NCT01102894
- Testing
- SmartPill
- Where
- United States
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- University of Minnesota
Obesity
Exenatide in Extreme Pediatric Obesity
Extreme pediatric obesity, the fastest growing category of obesity in youth, is associated with high risk for developing cardiovascular disease (CVD) and type 2 diabetes (T2DM).
- Trial name
- NCT01237197
- Testing
- Exenatide
- Where
- 2 sites in United States
- Volunteers
- 26 people
- Sponsor
- University of Minnesota
Schizophrenia, Smoking Cessation
Varenicline and Smoking Cessation in Schizophrenia
There is a strong association between smoking and schizophrenia with prevalence rates ranging from 74% to 90%, versus a national average of 30% in nonschizophrenic individuals.
- Trial name
- VSCS (NCT01111149)
- Testing
- Sugar Pill, Varenicline, Bupropion HCl
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- University of Minnesota
Anxiety
Anxiety Self-Management for ICU Patients Receiving Mechanical Ventilation
The purpose of this study is to test whether patients who are receiving mechanical ventilation in the ICU who listened to preferred, relaxing music whenever they desire for as long as they desire will have less anxiety, receive…
- Trial name
- NCT00440700
- Testing
- Anxiety Self-Management, Patient preferred relaxing music, Control 1: Noise-cancelling headphones, Control 2: Standard of Care
- Where
- United States
- Volunteers
- 364 people
- Sponsor
- University of Minnesota
Chronic Insomnia, Primary Insomnia
Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study
Chronic insomnia is a major public health problem that affects about 10% of adults and is associated with serious and distressful health consequences such as depression, anxiety and reduced quality of life.
- Trial name
- MVP#1 (NCT00515177)
- Testing
- Mindfulness-Based Stress Reduction, eszopiclone
- Where
- 2 sites in United States
- Volunteers
- 30 people
- Sponsor
- University of Minnesota
Obesity, Morbid
GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
The prevalence of severely obese children is on the rise. Behavioral therapies for weight loss are successful in some, but others need more aggressive approaches such as drug therapy.
- Trial name
- NCT00886626
- Testing
- Exenatide
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- University of Minnesota
Compulsive Sexual Behavior
Double-Blind Naltrexone in Compulsive Sexual Behavior
The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in compulsive sexual behavior. Twenty subjects with DSM-IV compulsive sexual behavior will receive 8 weeks of naltrexone or placebo.
- Trial name
- NCT00467558
- Testing
- Naltrexone, Sugar pill
- Where
- United States
- Volunteers
- 7 people
- Sponsor
- University of Minnesota
HIV Infection
Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study)
This study will examine whether interleukin-2 (IL-2) plus antiretroviral therapy (ART) slows HIV disease progression in patients with low CD4+ T cell counts compared with patients taking ART alone.
- Trial name
- SILCAAT (NCT00013611)
- Testing
- Proleukin
- Where
- United States
- Volunteers
- 1,695 people
- Sponsor
- University of Minnesota